This is the first study to investigate the association between concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) or antibiotics with proton pump inhibitors (PPIs) and the risk of acute ...
Approval of Journavx for acute pain marks the first new class of acute pain medication approved by the FDA in over 20 years.